Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA04000024 4-HDoHE cPLA2i 1.0 BCD110605C28 0.323 pmol/ml medium
LMFA04000024 4-HDoHE cPLA2i 1.0 BCD110605C30 0.315 pmol/ml medium
LMFA04000024 4-HDoHE cPLA2i 1.0 BCD110605C29 0.352 pmol/ml medium
LMFA04000024 4-HDoHE cPLA2i 20.0 BCD110605C64 0.463 pmol/ml medium
LMFA04000024 4-HDoHE cPLA2i 20.0 BCD110605C66 0.53 pmol/ml medium
LMFA04000024 4-HDoHE cPLA2i 20.0 BCD110605C65 0.498 pmol/ml medium
LMFA04000024 4-HDoHE PLDi 1.0 BCD110605C18 0.332 pmol/ml medium
LMFA04000024 4-HDoHE PLDi 1.0 BCD110605C16 0.322 pmol/ml medium
LMFA04000024 4-HDoHE PLDi 1.0 BCD110605C17 0.351 pmol/ml medium
LMFA04000024 4-HDoHE PLDi 20.0 BCD110605C52 0.758 pmol/ml medium
LMFA04000024 4-HDoHE PLDi 20.0 BCD110605C53 0.872 pmol/ml medium
LMFA04000024 4-HDoHE PLDi 20.0 BCD110605C54 0.752 pmol/ml medium
LMFA04000024 4-HDoHE KDO+cPLA2i 1.0 BCD110605C31 0.252 pmol/ml medium
LMFA04000024 4-HDoHE KDO+cPLA2i 1.0 BCD110605C32 0.255 pmol/ml medium
LMFA04000024 4-HDoHE KDO+cPLA2i 1.0 BCD110605C33 0.265 pmol/ml medium
LMFA04000024 4-HDoHE KDO+cPLA2i 20.0 BCD110605C69 0.299 pmol/ml medium
LMFA04000024 4-HDoHE KDO+cPLA2i 20.0 BCD110605C67 0.316 pmol/ml medium
LMFA04000024 4-HDoHE KDO+cPLA2i 20.0 BCD110605C68 0.327 pmol/ml medium
LMFA04000024 4-HDoHE KDO+PLDi 1.0 BCD110605C21 0.29 pmol/ml medium
LMFA04000024 4-HDoHE KDO+PLDi 1.0 BCD110605C19 0.267 pmol/ml medium
LMFA04000024 4-HDoHE KDO+PLDi 1.0 BCD110605C20 0.282 pmol/ml medium
LMFA04000024 4-HDoHE KDO+PLDi 20.0 BCD110605C56 0.414 pmol/ml medium
LMFA04000024 4-HDoHE KDO+PLDi 20.0 BCD110605C57 0.442 pmol/ml medium
LMFA04000024 4-HDoHE KDO+PLDi 20.0 BCD110605C55 0.509 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.23 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.178 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.21 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.162 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.154 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.13 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+PLDi 1.0 BCD110605C25 0.285 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+PLDi 1.0 BCD110605C27 0.239 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+PLDi 1.0 BCD110605C26 0.23 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+PLDi 20.0 BCD110605C61 0.162 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+PLDi 20.0 BCD110605C62 0.167 pmol/ml medium
LMFA04000024 4-HDoHE KDO+ATP+PLDi 20.0 BCD110605C63 0.137 pmol/ml medium
LMFA04000024 4-HDoHE KDO + ATP 1.0 BCD110605C15 0.256 pmol/ml medium
LMFA04000024 4-HDoHE KDO + ATP 1.0 BCD110605C14 0.265 pmol/ml medium
LMFA04000024 4-HDoHE KDO + ATP 1.0 BCD110605C13 0.292 pmol/ml medium
LMFA04000024 4-HDoHE KDO + ATP 20.0 BCD110605C49 0.214 pmol/ml medium
LMFA04000024 4-HDoHE KDO + ATP 20.0 BCD110605C50 0.199 pmol/ml medium
LMFA04000024 4-HDoHE KDO + ATP 20.0 BCD110605C51 0.194 pmol/ml medium
LMFA04000024 4-HDoHE KDO 1.0 BCD110605C08 0.26 pmol/ml medium
LMFA04000024 4-HDoHE KDO 1.0 BCD110605C07 0.259 pmol/ml medium
LMFA04000024 4-HDoHE KDO 1.0 BCD110605C09 0.231 pmol/ml medium
LMFA04000024 4-HDoHE KDO 20.0 BCD110605C45 0.485 pmol/ml medium
LMFA04000024 4-HDoHE KDO 20.0 BCD110605C44 0.524 pmol/ml medium
LMFA04000024 4-HDoHE KDO 20.0 BCD110605C43 0.486 pmol/ml medium
LMFA04000024 4-HDoHE C 0.0 BCD110605C03 0.174 pmol/ml medium
LMFA04000024 4-HDoHE C 0.0 BCD110605C01 0.272 pmol/ml medium